









Markets
/
Stocks
/
nasdaq-lgvn
/

Longeveron Inc

LGVN

View Detailed Chart

1.610USD

-0.025-1.53%

Market hours （ET）Quotes delayed by 15 min

24.08MMarket Cap

LossP/E TTM



Longeveron Inc

1.610

-0.025-1.53%

Overview Company Financials

Financials

Intraday

30m

Today

-1.53%

5 Days

-3.59%

1 Month

+22.90%

6 Months

+9.52%

Year to Date

-6.94%

1 Year

-44.29%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

8.887

Target Price

443.58%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Longeveron Inc

LGVN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(3)

Neutral(4)

Buy(6)

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.007

Neutral

RSI(14)

58.830

Neutral

STOCH(KDJ)(9,3,3)

40.532

Neutral

ATR(14)

0.123

High Vlolatility

CCI(14)

7.032

Neutral

Williams %R

42.308

Buy

TRIX(12,20)

0.930

Sell

StochRSI(14)

73.727

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

1.607

Buy

MA10

1.648

Sell

MA20

1.563

Buy

MA50

1.391

Buy

MA100

1.467

Buy

MA200

1.644

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.

Ticker SymbolLGVN

CompanyLongeveron Inc

CEOMr. Wa'el Hashad

Websitehttps://www.longeveron.com/